Hematopathology III: Bleeding Disorders Flashcards

(39 cards)

1
Q

What are hemorrhagic diatheses?

A

Disorders characterized by abnormal bleeding, either spontaneously or after trauma/surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What 3 main factors control bleeding?

A

Integrity of the blood vessel wall
Platelet function
Clotting cascade (to form fibrin mesh)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What does a bleeding time test measure?

A

The time it takes for a small skin cut to stop bleeding — a clinical test of platelet function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the normal platelet count?

A

150,000–450,000/μL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does Prothrombin Time (PT) test?

A

Measures the extrinsic and common clotting pathways

Uses tissue thromboplastin and calcium (Ca²⁺)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What does Partial Thromboplastin Time (PTT) test?

A

Measures the intrinsic and common clotting pathways

Uses kaolin, phospholipid, and calcium (Ca²⁺)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does “increased fragility of vessels” refer to?

A

condition where blood vessels are more prone to rupture, leading to bleeding into the skin, despite normal platelet and clotting function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are common causes of increased vessel fragility?

A
  • Vitamin C deficiency (Scurvy) – weakens collagen in vessel walls
  • Chronic glucocorticoid use – causes vessel wall thinning
  • Systemic amyloidosis – deposits in vessels weaken their structure
  • Ehlers-Danlos syndrome – genetic connective tissue disorder affecting collagen
  • Infections and hypersensitivity vasculitis – inflammation damages vessel walls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What symptoms are seen in patients with fragile blood vessels?

A

Petechiae (small pinpoint bleeding) and ecchymoses (larger bruises)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the lab findings in increased vessel fragility?

A

Normal PT (prothrombin time)
Normal PTT (partial thromboplastin time)
Normal platelet count

→ Because the issue is with the blood vessels, not the clotting system or platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the two types of platelet disorders?

A
  • Quantitative – Low platelet count (thrombocytopenia)
  • Qualitative – Platelets don’t work properly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What causes thrombocytopenia (low platelet count)?

A

mostly due to decreased production and increased destruction from
- drugs
- infections
- aplastic anemia
- metastases
- leukemias
- autoimmune (e.g., idiopathic thrombocytopenic purpura)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are qualitative platelet disorders?

A
  • Acquired: uremia, myeloproliferative neoplasms (MPN)
  • Inherited: Bernard-Soulier syndrome, Glanzmann’s thrombasthenia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Bernard-Soulier syndrome?

A

GPIb-V-IX glycoprotein defect/missing → adhesion problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is Glanzmann’s thrombasthenia?

A

GPIIb-IIIa glycoproteins defect/missing → aggregation problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are common symptoms of platelet disorders?

A
  • Petechiae (small red spots), ecchymoses (bruises)
  • Easy bruising
  • Epistaxis (nosebleeds)
  • Menorrhagia (heavy menstrual bleeding)
  • Excessive bleeding from minor trauma
17
Q

What are the lab findings in platelet disorders?

A
  • Normal PT and PTT
  • Prolonged bleeding time (due to impaired platelet plug formation)
18
Q

What are coagulation disorders?

A

Disorders affecting the clotting cascade, leading to impaired fibrin clot formation

19
Q

What lab findings are typical of coagulation disorders?

A

Prolonged PT, PTT, or both — depending on which factor(s) are deficient

20
Q

What are the main types of coagulation disorders?

A

Acquired:
- Vitamin K deficiency (affects prothrombin (II), VII, IX, X)
- Liver disease (↓ synthesis of clotting factors)

Hereditary:
- Factor VIII deficiency (Hemophilia A)
- Other congenital factor deficiencies

21
Q

What are typical symptoms of coagulation disorders?

A
  • Normal bleeding time, but impaired clot formation
  • Petechiae are usually absent
  • Massive bleeding after surgery or trauma
  • Internal hemorrhage including: Intramuscular bleeds, Joint bleeds (hemarthroses)
22
Q

What is Hemophilia A?

A

most common genetic bleeding disorder caused by a deficiency or dysfunction of clotting factor VIII, leading to serious bleeding

23
Q

What is the genetic pattern of Hemophilia A?

A
  • X-linked recessive
  • Affects mostly males but homozygous females can also be affected
  • 30% of cases occur without a family history (spontaneous mutations)
24
Q

When does severe bleeding occur in Hemophilia A?

A

When factor VIII levels fall below 1% of normal because of either:
- Quantitative: Not enough factor VIII
- Qualitative: Factor VIII is present but doesn’t function properly

25
What are clinical signs of Hemophilia A?
- Hemarthrosis (bleeding into joints) - Muscle hematomas - Prolonged bleeding after injury or surgery - NO petechiae (because platelet function is normal)
26
What is the treatment for Hemophilia A?
Infusion of recombinant factor VIII to replace the missing clotting protein
27
What is Hemophilia B?
genetic bleeding disorder that is clinically identical to Hemophilia A but caused by a deficiency in clotting factor IX
28
How is Hemophilia B inherited?
- X-linked recessive - Primarily affects males - Diagnosis requires assay of clotting factor levels to distinguish from Hemophilia A
29
What is the treatment for Hemophilia B?
Infusion of recombinant factor IX
30
What is von Willebrand Factor (vWF)?
A large adhesive glycoprotein crucial for hemostasis that mediates platelet adhesion to damaged endothelium and stabilizes factor VIII (protects it from degradation)
31
Where is vWF synthesized and found?
synthesized in endothelial cells and megakaryocytes, stored in subendothelial tissue and released at sites of injury where it binds to platelets and collagen to form the initial plug
32
What is von Willebrand disease (vWD)?
autosomal dominant disease that causes reduced vWF which leads to faster degradation of factor VIII and symptoms are mostly due to platelet adhesion defects (not clotting cascade)
33
What is Disseminated Intravascular Coagulation (DIC)?
serious condition where the coagulation system is over-activated throughout the body, causing both clotting and bleeding
34
What triggers DIC?
DIC is a secondary complication of many conditions from either release of tissue factor into circulation or endothelial damage
35
What happens in DIC? (Pathophysiology)
- Widespread activation of clotting → Microthrombi (tiny clots in vessels) - Leads to microinfarcts and fibrin deposits in vessels - RBC hemolysis → microangiopathic hemolytic anemia - Consumption of platelets and coagulation factors → Severe bleeding
36
What causes the activation of clotting in DIC?
Circulating tissue factor from: - Placental tissue (obstetrics) complications - carcinoma cells - Leukemia treatment (chemo) - Monocytes releasing cytokines Endothelial damage: - Antigen-antibody complexes - Exotoxins - Severe trauma
37
What’s the difference between acute and chronic DIC?
- Acute DIC: Mainly bleeding (e.g., obstetric cases) - Chronic DIC: Mainly clotting/thrombotic symptoms (e.g., cancer)
38
What are the lab findings in DIC?
- Prolonged: Bleeding time, PT, PTT - Elevated D-dimers (from fibrin breakdown) - Thrombocytopenia and signs of consumptive coagulopathy - Schistocytes on blood smear (RBC fragments)
39
What is the treatment for DIC?
Treat the underlying cause - Supportive care: Transfusions of platelets, clotting factors if bleeding and anticoagulants like heparin in chronic cases with clotting